Granulocyte chemotactic activity in exhaled breath condensate of healthy subjects and patients with COPD

Chest

Volumn 131, Issue 6, 2007, Pages 1672-1677

  Corhay, Jean Louis ^a   Hemelaers, Laurent ^b   Henket, Monique ^b   Sele, Jocelyne ^b   Louis, Remind ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Airway inflammation; Chemotactic activity; COPD; Eosinophils; Exhaled breath condensate; Neutrophils

Indexed keywords

CHEMOATTRACTANT; INTERLEUKIN 8 ANTIBODY;

ADULT; AGED; ARTICLE; BREATHING; CELL MIGRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; EOSINOPHIL; EXHALED BREATH CONDENSATE; FEMALE; GRANULOCYTE; HEATING; HUMAN; MALE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; SMOKING;

EID: 34250813716     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2225     Document Type: Article

References (26)

1. 4. Chest 2003; 123:1240-1247
2. Montuschi P. Exhaled breath condensate analysis in patients with COPD. Clin Chim Acta 2005; 356:22-34
3. Horváth I, Hunt J, Barnes PJ, on behalf of the ATS/ERS Task Force on Exhaled Breath Condensate. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26:523-548
4. Montuschi P, Kharitonov SA, Ciabattoni G. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003; 58:585-588
5. 4 and 8-isoprostane in exhaled breath condensate of patients with exacerbation of COPD. Thorax 2003; 58:294-298
6. 4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 2005; 127:1553-1559
7. Cunningham S, McColm JR, Ho LP, et al. Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. Eur Respir J 2000; 15: 955-957
8. Simpson JL, Wood LG, Gibson PC. Inflammatory mediators in exhaled breath, induced sputum and saliva. Clin Exp Allergy 2005; 35:1180-1185
9. Garey K, Neuhauser MM, Robbins RA, et al. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 2004; 125:22-26
10. Sutherland ER, Martin RJ. Airway inflammation in chronic obstructive pulmonaiy disease; comparisons with asthma. J Allergy Clin Immunol 2003; 112:819-827
11. Pauwels RA, Buist AS, Calverley PMA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop report. Am J Respir Crit Care Med 2001; 163:1256-1276 (updated 2003; available at www.goklcopd.com. Accessed December 19, 2003)
12. Hatzelmann A, Tenor H, Schudt C. Differential effects of nonselective and selective phosphodiesterase inhibitor on human cosinophil function. Br J Pharmacol 1995; 114:821-831
13. Effros RM, Biller J, Foss B, et al. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med 2003; 168:1500-1505
14. 4 are increased in sputum compared to bronchoalveolar lavage and exhaled breath condensate [abstract]. Am J Respir Crit Care Med 2005; A844
15. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction: accumulation of neutrophils in the lung of cigarette smokers. Am Rev Respir Dis 1983; 128:S33-S3S
16. Thomas RA, Green RH, Brightling CE, et al. The influence of age on induced sputum differential cell counts in normal subjects. Chest 2004; 126:1811-1814
17. Thurlbeck WM. Pathology of chronic obstructive pulmonary disease. Clin Chest Med 1990; 11:389-404
18. Stefano A, Capelli A, Lusuardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158:1277-1285
19. Ronchi MC, Piragino C, Rosi E, et al. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax 1996; 51:1000-1004
20. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002; 121:151-155
21. Confalonieri M, Mainardi E, Della Porta R, et al. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonaiy disease. Thorax 1998; 53:583-585
22. Yildiz F, Kaur AC, Ilgazli A, et al. Inhaled corticosteroids may reduce neutrophilic inflammation in patients with stable chronic obstructive pulmonary disease. Respiration 2000; 67:71-76
23. Llewellyn-Jones CG, Harris TA, Stockley RA. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Am J Respir Crit Care Med 1996; 153:616-621
24. Llewellyn-Jones CG, Hill SL, Stockley RA. Effect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitro. Thorax 1994; 49:207-212
25. Culpitt SV, Maziak W, Loukadis S, et al. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 160:1635-1639
26. Keatings VM, Jatakanon A, Worsdell YM, et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155:542-548